CXCL12 expression was significantly higher in human prostate cancer tissue than hyperplastic prostate tissues [25], suggesting that CXCL12 has an autocrine regulatory role via its receptor CXCR4 in the regulation of prostate cancer cell migration, invasion, and metastasis [26]. The gene discussed is CXCR4; the disease is prostate carcinoma.